Lawrence T. Goodnough
Stanford University
417 Papers
5K Citations
Lawrence T. Goodnough is an academic researcher from Stanford University. The author has contributed to research in topics: Blood transfusion & Medicine. The author has an hindex of 85, co-authored 417 publications. Previous affiliations of Lawrence T. Goodnough include American Red Cross & Washington University in St. Louis.
Chat about Author
Papers
Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation
H Khoury,K. Trinkaus,Mei-Jie Zhang,Douglas Adkins,R Brown,Ravi Vij,Lawrence T. Goodnough,Margaret K. Ma,Howard L. McLeod,Shalini Shenoy,Mary M. Horowitz,John F. DiPersio +11 more
TL;DR: It is concluded that prophylactic HCQ is well tolerated and associated with a low incidence of severe acute GVHD and an ongoing placebo-controlled randomized trial will further determine what role HCQ plays in preventing GV HD after allografting.
27
The Judicious Use of Recombinant Factor VIIa
TL;DR: The benefit of rFVIIa in most nonhemophilia settings remains uncertain as the majority of clinical trials have not consistently demonstrated beneficial effects as determined by reduced bleeding, decreased blood product utilization, or have not demonstrated a mortality benefit.
27
How I use clinical decision support to improve red blood cell utilization
TL;DR: This work describes its own experience using well‐designed and highly targeted CDS to promote restrictive transfusion practices and improve red blood cell utilization, with a 42% reduction in blood transfusions from 2009 through 2015, accompanied by improved clinical outcomes.
26
Specific binding of thrombin by human peripheral blood monocytes: possible role in the clearance of activated clotting factors from the circulation.
TL;DR: It is indicated that PBM may play a role in the clearance of activated clotting factors from the circulation and serve as an experimental model to study the role of the RES as a defense against thrombosis.
26
Granulocyte collection efficiency and yield are enhanced by the use of a higher interface offset during apheresis of donors given granulocyte-colony-stimulating factor.
TL;DR: To optimize the latter variable, the effect of various interface offset settings during apheresis on granulocytes collection efficiency (GCE) and yield was determined in normal donors given granulocyte‐colony‐stimulating factor (G‐CSF).
26